{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:an2-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","type":"Company","slug":"an2-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/an2-therapeutics-inc","legal_name":"AN2 Therapeutics, Inc.","display_name":"AN2 Therapeutics, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-09-28T14:40:52.37647+00:00","observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":"2026-09-28T14:40:52.37647+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/an2-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/an2-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/an2-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/an2-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/an2-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/an2-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":19,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":19,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-28T14:40:52.37647+00:00","observed_at":"2026-09-28T14:40:52.37647+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:legal_name:1","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"AN2 Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"AN2 Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/an2-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:52.37647+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:entity_status:3","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/an2-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:52.37647+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:published_fact:4","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/an2-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:52.37647+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:5","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eric-easom","object_label":null,"object_source_name_forms":[],"value":"Eric Easom: President, Chief Executive Officer and Board Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Eric Easom: President, Chief Executive Officer and Board Chair","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:6","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gilbert-lynn-marks-antx","object_label":null,"object_source_name_forms":[],"value":"Gilbert Lynn Marks: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Gilbert Lynn Marks: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:3","source_type":"sec_proxy","title":"DEF 14A antx-20260422.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-02T02:50:00.039258+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:7","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gilbert-lynn-marks-m-d","object_label":null,"object_source_name_forms":[],"value":"Gilbert Lynn Marks, M.D.: Class I Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Gilbert Lynn Marks, M.D.: Class I Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:8","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-zakrzewski-antx","object_label":null,"object_source_name_forms":[],"value":"Joseph Zakrzewski: Class III Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Joseph Zakrzewski: Class III Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:9","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kabeer-aziz-antx","object_label":null,"object_source_name_forms":[],"value":"Kabeer Aziz: Class I Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Kabeer Aziz: Class I Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:10","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-fitzpatrick-antx","object_label":null,"object_source_name_forms":[],"value":"Margaret FitzPatrick: Class II Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Margaret FitzPatrick: Class II Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:11","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:melvin-spigelman-antx","object_label":null,"object_source_name_forms":[],"value":"Melvin Spigelman: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Melvin Spigelman: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:3","source_type":"sec_proxy","title":"DEF 14A antx-20260422.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-02T02:50:00.039258+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:12","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:melvin-spigelman-m-d","object_label":null,"object_source_name_forms":[],"value":"Melvin Spigelman, M.D.: Class II Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Melvin Spigelman, M.D.: Class II Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:13","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patricia-martin-antx","object_label":null,"object_source_name_forms":[],"value":"Patricia Martin: Class II Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Patricia Martin: Class II Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:14","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rob-readnour-antx","object_label":null,"object_source_name_forms":[],"value":"Rob Readnour: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Rob Readnour: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:3","source_type":"sec_proxy","title":"DEF 14A antx-20260422.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-02T02:50:00.039258+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:15","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rob-readnour-ph-d","object_label":null,"object_source_name_forms":[],"value":"Rob Readnour, Ph.D.: Class I Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Rob Readnour, Ph.D.: Class I Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:16","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephanie-wong-antx","object_label":null,"object_source_name_forms":[],"value":"Stephanie Wong: Class III Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Stephanie Wong: Class III Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:17","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eric-easom","object_label":null,"object_source_name_forms":[],"value":"Eric Easom: President, Chief Executive Officer and Board Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Eric Easom: President, Chief Executive Officer and Board Chair","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:18","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:joshua-eizen-antx","object_label":null,"object_source_name_forms":[],"value":"Joshua Eizen: Chief Legal Officer and Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Joshua Eizen: Chief Legal Officer and Chief Operating Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-22","valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:3","source_type":"sec_proxy","title":"DEF 14A antx-20260422.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-02T02:50:00.039258+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":"2026-04-22","effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:19","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lucy-day","object_label":null,"object_source_name_forms":[],"value":"Lucy Day: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Lucy Day: Chief Financial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b92e141d-3c35-4f76-afa0-2d12534e9412:leadership_role:20","subject_id":"alpha:company:b92e141d-3c35-4f76-afa0-2d12534e9412","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sanjay-chanda-ph-d","object_label":null,"object_source_name_forms":[],"value":"Sanjay Chanda, Ph.D.: Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Sanjay Chanda, Ph.D.: Chief Development Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:52.37647+00:00","sources":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null}],"source_date":"2026-04-22T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:52.37647+00:00","reviewed_at":"2026-09-28T14:40:52.37647+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/an2-therapeutics-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:52.37647+00:00","locator":null},{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-170314","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-05T23:15:52.926994+00:00","locator":null},{"id":"alpha:evidence:company:b92e141d-3c35-4f76-afa0-2d12534e9412:3","source_type":"sec_proxy","title":"DEF 14A antx-20260422.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm","source_date":"2026-04-22T00:00:00+00:00","retrieved_at":"2026-09-02T02:50:00.039258+00:00","locator":null}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[]}